REFLECT2D: Real-time Engagement For Learning to Effectively Control Type 2 Diabetes
Project Number1R01DK137803-01A1
Former Number1R01DK137803-01
Contact PI/Project LeaderVAJRAVELU, MARY ELLEN
Awardee OrganizationUNIVERSITY OF PITTSBURGH AT PITTSBURGH
Description
Abstract Text
ABSTRACT
Youth-onset type 2 diabetes (T2D) represents a growing threat to health equity. Continuously increasing in
incidence, T2D is up to 9-fold more common among racial-ethnic minoritized youth, and approximately half of
affected youth live in poverty. T2D diagnosis in childhood often results in severe complications by early
adulthood, as well as reduced life expectancy. Modification of diabetes-related health behaviors, including
nutrition and physical activity, is central to management, but several barriers exist for adolescents and young
adults (AYA) with T2D. These include hyperglycemia unawareness, delayed or burdensome glycemic feedback,
and the difficulty of attending intensive in-person interventions. Fortunately, wearable continuous glucose
monitors (CGMs) enable the development of remote just-in-time adaptive interventions that use real-time data
at the right time, in the right context to promote behavior change. With the transition to adult care, AYA with T2D
are particularly well suited to benefit from a CGM-supported intervention that supports development of diabetes
self-management skills and engagement in health behaviors. To lay the foundation for such an intervention, we
have developed Healthmine, a mobile app that integrates CGM, activity trackers, and diet logging for use by
individuals with diabetes. The objective for this R01 proposal, REFLECT2D, is to evaluate the time-dependent
glycemic impact of Healthmine app-based prompts. Aligned with the COM-B Model for Behavior Change,
Healthmine prompts are designed to foster motivation and actual engagement in health behaviors by providing
of an opportunity to review real-time data and by supporting the development of an improved capability to
interpret and act on such data. We will enroll 100 AYA ages 16-24 with T2D in a clinical trial, beginning with a
baseline study visit and educational session led by a certified diabetes education and care specialist and
registered dietitian. After a 10-day run-in with CGM to evaluate baseline glycemic control, we will conduct a 90-
day micro-randomized trial (MRT), in which each AYA will be randomized with equal (1/3) probability once daily
to receive a physical activity-focused prompt, a nutrition-focused prompt, or no prompt. In MRT, each participant
acts as their own control. After MRT, AYA will attend a second study visit to assess intermediate outcomes and
will continue to wear CGM for a 90-day observational period without app prompts, followed by final study visit,
to assess duration of effect on motivation and glycemic outcomes. Our approach will allow us to determine the
effects of prompts on short-term CGM-measured glycemia during MRT (Aim 1), characterize ongoing CGM and
app use and longer-term impact on glycemia during an observational period (Aim 2), and evaluate changes in
outcomes from baseline to follow-up, including glycemia and behavioral measures, as well as the role of
motivation as a mediator (Aim 3). Findings will inform the development of a CGM-based just-in-time adaptive
intervention, which will directly address barriers to in-person engagement in health behavior change, allowing
for scalability and ultimately reducing the widening health disparities caused by youth-onset T2D.
Public Health Relevance Statement
NARRATIVE
Youth-onset type 2 diabetes is rapidly increasing in incidence, carries a high risk of severe complications in
early adulthood, and disproportionately impacts marginalized communities. Adolescents and young adults with
type 2 diabetes often face barriers to healthy lifestyle change and diabetes self-management, including limited
or delayed feedback on how such health behavior changes affect blood sugar. Our study, REFLECT2D, will
evaluate use a novel smartphone app pairing real-time health behavior and glycemic data, laying the
foundation for future interventions that use the right type of data at the right time to support health behavior
change, ultimately improving outcomes for adolescents and young adults with type 2 diabetes.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
004514360
UEI
MKAGLD59JRL1
Project Start Date
01-July-2024
Project End Date
30-June-2029
Budget Start Date
01-July-2024
Budget End Date
30-June-2025
Project Funding Information for 2024
Total Funding
$594,591
Direct Costs
$403,003
Indirect Costs
$191,588
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Diabetes and Digestive and Kidney Diseases
$594,591
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01DK137803-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01DK137803-01A1
Patents
No Patents information available for 1R01DK137803-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01DK137803-01A1
Clinical Studies
No Clinical Studies information available for 1R01DK137803-01A1
News and More
Related News Releases
No news release information available for 1R01DK137803-01A1
History
No Historical information available for 1R01DK137803-01A1
Similar Projects
No Similar Projects information available for 1R01DK137803-01A1